The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saribasak, H.
Right arrow Articles by Buerstedde, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saribasak, H.
Right arrow Articles by Buerstedde, J.-M.
The Journal of Immunology, 2006, 176: 365-371.
Copyright © 2006 by The American Association of Immunologists

Uracil DNA Glycosylase Disruption Blocks Ig Gene Conversion and Induces Transition Mutations1

Huseyin Saribasak*, Nesibe Nur Saribasak*, Fatih M. Ipek*, Joachim W. Ellwart{dagger}, Hiroshi Arakawa* and Jean-Marie Buerstedde2,*

* Institute of Molecular Radiobiology, GSF, Neuherberg, Germany; and {dagger} Institute of Molecular Immunology, GSF, München-Grosshardern, Germany

Ig gene conversion is most likely initiated by activation-induced cytidine deaminase-mediated cytosine deamination. If the resulting uracils need to be further processed by uracil DNA glycosylase (UNG), UNG inactivation should block gene conversion and induce transition mutations. In this study, we report that this is indeed the phenotype in the B cell line DT40. Ig gene conversion is almost completely extinguished in the UNG-deficient mutant and large numbers of transition mutations at C/G bases accumulate within the rearranged Ig L chain gene (IgL). The mutation rate of UNG-deficient cells is about seven times higher than that of pseudo V gene-deleted ({psi}V) cells in which mutations arise presumably after uracil excision. In addition, UNG-deficient cells show relatively more mutations upstream and downstream of the VJ segment. This suggests that hypermutating B cells process activation-induced cytidine deaminase-induced uracils with approximately one-seventh of uracils giving rise to mutations depending on their position.




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
J. M. Di Noia, G. T. Williams, D. T.Y. Chan, J.-M. Buerstedde, G. S. Baldwin, and M. S. Neuberger
Dependence of antibody gene diversification on uracil excision
J. Exp. Med., December 24, 2007; 204(13): 3209 - 3219.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Chatterji, S. Unniraman, K. M. McBride, and D. G. Schatz
Role of Activation-Induced Deaminase Protein Kinase A Phosphorylation Sites in Ig Gene Conversion and Somatic Hypermutation
J. Immunol., October 15, 2007; 179(8): 5274 - 5280.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Y. Yang, S. D. Fugmann, H. S. Gramlich, and D. G. Schatz
Activation-induced Cytidine Deaminase-mediated Sequence Diversification Is Transiently Targeted to Newly Integrated DNA Substrates
J. Biol. Chem., August 31, 2007; 282(35): 25308 - 25313.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Y. Yang, S. D. Fugmann, and D. G. Schatz
Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences
J. Exp. Med., December 25, 2006; 203(13): 2919 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. S. Tang and A. Martin
NHEJ-deficient DT40 cells have increased levels of immunoglobulin gene conversion: evidence for a double strand break intermediate
Nucleic Acids Res., December 4, 2006; 34(21): 6345 - 6351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Schoetz, M. Cervelli, Y.-D. Wang, P. Fiedler, and J.-M. Buerstedde
E2A Expression Stimulates Ig Hypermutation
J. Immunol., July 1, 2006; 177(1): 395 - 400.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.